๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Evaluation of xanthotoxol for central nervous system activity

โœ Scribed by Sethi, O.P.; Anand, K.K.; Gulati, O.D.

Book ID
123314044
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
967 KB
Volume
36
Category
Article
ISSN
0378-8741

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Aminoalkylindoles with Central Nervous S
Aminoalkylindoles with Central Nervous System Activity
โœ Welstead, William J.; DaVanzo, John P.; Helsley, Grover C.; Lunsford, Carl D.; T ๐Ÿ“‚ Article ๐Ÿ“… 1967 ๐Ÿ› American Chemical Society ๐ŸŒ English โš– 676 KB
Phase II evaluation of topotecan for ped
Phase II evaluation of topotecan for pediatric central nervous system tumors
โœ Susan M. Blaney; Peter C. Phillips; Roger J. Packer; Richard L. Heideman; Stacey ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 473 KB ๐Ÿ‘ 2 views

## BACKGROUND. Topotecan is a topoisomerase I inhibitor that has good penetration across the blood-brain barrier and significant antitumor activity against human brain tumor xenografts. In a Phase I trial in children with refractory cancer, topotecan was well tolerated when administered as a 24-ho